NasdaqCM - Delayed Quote USD

Gelteq Limited (GELS)

Get top stock picks

0.9000 +0.0068 (+0.76%)

At close: September 4 at 4:00:01 PM EDT

0.8498 -0.0502 (-5.58%)

After hours: September 4 at 7:59:39 PM EDT

Get top stock picks

Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway

GlobeNewswire 3mo ago

GELS
+0.76%
Gelteq Announces USD $3.5 Million Strategic Debt Financing to Accelerate Commercialization and Support Revenue Growth

GlobeNewswire 3mo ago

GELS
+0.76%
Gelteq Provides Corporate Update: Launching Veterinary and Human Clinical Trials, Pharmaceutical Pipeline Expanding Across Multiple Programs

GlobeNewswire 2mo ago

GELS
+0.76%
Healthy Extracts Q1 2026 Net Revenue Up 73% to Record $1.6 Million, Driving Positive EBITDA

ACCESS Newswire 3mo ago

HYEX

GELS
+0.76%
Gelteq Successfully Completes Veterinary Palatability Trials with Kemin, Further Validating Gelteq® Technology for Animal Health Applications

GlobeNewswire 2mo ago

GELS
+0.76%
Gelteq Establishes Center of Excellence in China to Accelerate Product Development and Commercial Expansion

GlobeNewswire 3mo ago

GELS
+0.76%
Q1 Virtual Investor Summit Presentations Now Available On Demand

ACCESS Newswire 5mo ago
Investor Summit Announces Q1 Presenter Line Up (Presentations 3/25, 1-on-1s 3/26)

ACCESS Newswire 5mo ago
Gelteq and Healthy Extracts to Expand Gel-Based Nutrition Technologies with New Strategic Manufacturing & Commercial Partnership

GlobeNewswire 6mo ago

GELS
+0.76%
HYEX
Gelteq announces preclinical results on medicinal cannabinoid absorption

TipRanks 7mo ago

GELS
+0.76%
Gelteq Furthers Asia Presence Through Partnership with Hong Kong Flag Football Program

GlobeNewswire 8mo ago

GELS
+0.76%
Gelteq Signs Three Year Sales Agreement with Shenzhen Mana Health Management Co. Strengthening Gelteq’s Nutritional Product Expansion into China

GlobeNewswire 8mo ago

GELS
+0.76%

Yahoo Finance

U.S. markets closed

Gelteq Limited (GELS)

Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway

Gelteq Announces USD $3.5 Million Strategic Debt Financing to Accelerate Commercialization and Support Revenue Growth

Gelteq Provides Corporate Update: Launching Veterinary and Human Clinical Trials, Pharmaceutical Pipeline Expanding Across Multiple Programs

Healthy Extracts Q1 2026 Net Revenue Up 73% to Record $1.6 Million, Driving Positive EBITDA

Gelteq Successfully Completes Veterinary Palatability Trials with Kemin, Further Validating Gelteq® Technology for Animal Health Applications

Gelteq Establishes Center of Excellence in China to Accelerate Product Development and Commercial Expansion

Q1 Virtual Investor Summit Presentations Now Available On Demand

Investor Summit Announces Q1 Presenter Line Up (Presentations 3/25, 1-on-1s 3/26)

Gelteq and Healthy Extracts to Expand Gel-Based Nutrition Technologies with New Strategic Manufacturing & Commercial Partnership

Gelteq announces preclinical results on medicinal cannabinoid absorption

Gelteq Furthers Asia Presence Through Partnership with Hong Kong Flag Football Program

Gelteq Signs Three Year Sales Agreement with Shenzhen Mana Health Management Co. Strengthening Gelteq’s Nutritional Product Expansion into China